期刊文献+

多支血管病变PCI术后相关危险因素及其对预后的影响 被引量:2

Risk factors of multivessel disease(MVD) after PCI and their effect on prognosis
下载PDF
导出
摘要 目的分析影响冠心病多支血管病变(MVD)患者经皮冠状动脉介入术(PCI)的危险因素及其对预后的影响。方法回顾性分析2005年12月至2010年12月该院行冠状动脉造影(CAG)明确为MVD病变并行PCI患者300例的临床资料,采用多因素Logistic回归分析影响其预后的危险因素。结果影响MVD患者PCI术后死亡的独立危险因素为:左室射血分数P=0.044,OR(95%CI)为2.617(1.025,6.679)、心力衰竭P=0.006,OR(95%CI)为4.379(1.529,12.538)、血管病变支数P=0.038,OR(95%CI)为2.663(1.055,6.723)及血运重建方式P=0.011,OR(95%CI)为0.431(0.226,0.821)。结论影响冠心病MVD患者PCI术后预后的独立危险因素为:EF、心力衰竭和血运重建方式;其中血运重建方式为影响预后最重要的独立危险因素。 Objective To investigate the risk factors of MVD patients with coronary heart disease after percutaneous coronary intervention(PCI) and their effect prognosis.Methods The clinical data of 300 MVD patients with coronary heart disease after PCI admitted from December 2005 to December 2010 were retrospectively analyzed based on coronary angiography(CAG).Logistic multivariate regression analysis on models were used to find the independent risk factors.Results The independent risk factors for prognosis of MVD patients with coronary heart disease after PCI were left ventricular ejection fraction[P=0.044,OR(95%CI)=2.617(1.025,6.679)],heart failure[P=0.006,OR(95%CI)=4.379(1.529,12.538)],the number of vascular disease[P=0.038,OR(95%CI)=2.663(1.055,6.723)] and revascularization way[P=0.011,OR(95%CI)=0.431(0.226,0.821)].Conclusion Independent risk factors affecting the prognosis of MVD patients with coronary heart disease after PCI are EF,heart failure and revascularization way;And revascularization way is the most important independent risk factors to influence the prognosis of MVD patients with coronary heart disease after PCI.
出处 《重庆医学》 CAS CSCD 北大核心 2013年第19期2208-2211,共4页 Chongqing medicine
基金 贵州省国际合作项目(黔科合外G字[2010]0732)
关键词 冠状动脉疾病 危险因素 多支血管病变 经皮冠状动脉介入术 coronary artery disease risk factors multivessel disease percutaneous coronary intervention
  • 相关文献

参考文献14

  • 1许官学,石蓓,王正龙,沈长银,郭小英.多支冠脉血管病变分次PCI的近期临床疗效[J].遵义医学院学报,2009,32(6):580-582. 被引量:5
  • 2Ribichini F, Taggart D. Implications of new ESC/EACTS guidelines on myocardial revascularization for patients with multivessel coronary artery disease[J]. EurJ Cardio?tho rae Surg,2011 ,39(5) :619-622.
  • 3郭永和,周玉杰,赵迎新,等.不完全血运重建策略对老年冠状动脉多支血管病变患者预后的影响[J].中国介人心脏病学杂志,2012 , 20(1): 9-11.
  • 4经皮冠状动脉介入治疗指南(2009)[J].中华心血管病杂志,2009,37(1):4-25. 被引量:546
  • 5Braunwald E,Antman EM,Beasley rw.? al. ACC/AHA 2002 guideline update for the management of patients with unstable anginaand non-S'T-segment elevation myo?cardial infarction summary article: are port of the Ameri?can College of Cardiology/ American Heart Association task force on practice guidelines[J].J ACC, 2002,40 (7) : 1366.
  • 6Park DW, Kim YH, et al. Long-term outcome of stents versus bypass surgery in diabetic and nondiabetic patients withmultivessel or left main coronary artery disease: a pooled analysis of 5775 individual patient data[n. Circ Cardiovasc Interv,2012,5(4) :467-475.
  • 7Chang TI, Shilane D, Kazi DS, et al. Multivessel coronary artery bypass grafting versus percutaneous coronary in?tervention in ESRD[J].J Am Soc Nephrol,2012,23(l2): 2042-2049.
  • 8Gao F, Zhou YJ, Shen H, et al. Meta-analysis of percuta?neous coronary intervention versus coronary artery bypass graft surgery in patients with diabetes and left main and/ or multivessel coronary artery disease[J]. Acta Diabetol, 2012,21:l.
  • 9Vasaiwala S, Williams DO. Revascularization for left main and multivessel coronary artery disease in the drug-elu?ting stent era: integration of recent drug-eluting stent tri?als[J]. Curr Cardiol Rep,2012,14(4) :468-476.
  • 10陈剑飞,张藜,黄岚.从SYNTAX研究评价多支血管病变血运重建的意义[J].心血管病学进展,2010,31(5):703-705. 被引量:3

二级参考文献30

  • 1CHANCE研究组.无保护左主干病变支架置入术预后及影响因素的分析——中国无保护左主干病变支架置入术注册(CHANCE)研究[J].中华心血管病杂志,2005,33(3):210-215. 被引量:19
  • 2Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿(译),David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志(中文版),2007,26(3):131-139. 被引量:59
  • 3Yang JH, Gwon HC, Cho SJ, et al. Comparison of coronary artery bypass gaffing with drug-eluting stent implantation for the treatment of muhivessel coronary artery disease. Ann Thorae Surg, 2008,85:65-70.
  • 4Park DW, Yun SC, Lee SW, et al. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of muhivessel coronary artery disease. Circulation, 2008, 117: 2079 -2086.
  • 5Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in muhivessel eoronary disease. N Engl J Med, 2008,358:331-341.
  • 6Harjai K J, Grines CL. Management of multivessel coronary disease : let us not shortchange drug-eluting stents. J Interv Cardiol, 2008,21:213-217.
  • 7Ong AT, van der Giessen WJ. Drug-eluting stents for interventional revascularization of coronary multivessel disease. J Interv Cardiol, 2005,18:447-453.
  • 8Kelbaek H, Thuesen L, Helqvist S, et al. The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial. J Am Coil Cardiol, 2006,47:449-455.
  • 9Spaulding C, Daemen J, Boersma E, et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med, 2007,356:989-997.
  • 10Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med, 2007,356 : 1030-1039.

共引文献552

同被引文献19

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部